Response to Kyra, Good evening Kyra, Thank you for posting insight on psychopharmacological interventions, and how they are individually addressed based on the client. In the study of mental health tools are given as evidence based research that allows providers and clinicians the ability to treat clients with the most effective course of treatment based on a clients history, formal assessments, and diagnosis. However, just as counselors may have to find a therapeutic approach and theory that may be a mixture of several theories is the same conception in psychopharmacological interventions. Therefore the need for psychopharmacological interventions is added resource that may deem to be beneficial when working with those that require additional
Client reported that he is currently attending to a psychiatric session once a month due to his bipolar disorder and that it is very helpful for him. He also stated that was prescribe Seroquel 30 mg once a day for the bipolar disorder, Luvox 30 mg for anxiety and depression once a day as well and one B12 for energy. He has been taking Seroquel and Luvox for more that tree yeas since he was diagnose with bipolar disorder and the B12 since he had the bypass surgery.
Pharmacological intervention is used in substance abuse cases for two purposes: as substitution therapy for addiction or dependence and to treat comorbid mental health conditions such as depression, ADHD, anxiety, and disruptive behavior disorders (Landsverk et al, 2009). AB will state the benefits of taking medication. He will gain an understanding of how his medication work in conjunction with TF-CBT. He will be able to state the names of his antipsychotic medication, dosages, frequency and side effects. There is little or no such evidence for adolescent populations. Because adolescents typically do not suffer from long-term addictions, pharmacological intervention for addiction has not generally been recommended (Landsverk et al,
Specific Therapeutic Intervention: With working towards treating the diagnosis there should be a consideration of medication. Medication may provide enough symptom relief to allow the client to participate in therapy.
With any medication prescribed it is the duty of the prescriber an any mental health professional working directly with that client to provide them with as much psychoeducation as possible. It is vital that the client understands the benefits and risks of the medication. FUrthermore, it is vital for the client to understand that the client must be willing to commit to the process of finding the correct cocktail if you will.
was free to terminate the session anytime should she feel it necessary. It was also vital to ensure that the sessions were neither confrontational and totally compliant with Emily’s view of the world ( Kingdom & Turkington, 1995) I encouraged Emily to describe her current problems and to give a detailed description of the problems and concentrate on a more recent problem. l was directive, active, friendly and used constructive feedback, containment of feelings to develop the relationship(Tarrier et al,1998).l used her interest in Christianity to engage her and because l showed an interest this became a regular point of conversation and strengthened the connection. I also demonstrated some flexibility in response to Emily’s needs and requirements at different stages of the treatment and intervention. It is not possible to maintain a sound collaborative therapeutic relationship without constant attention to the changing situation and requirements of a patient (Gamble and Brennan, 2006). Since the development of antipsychotic medication and dominance of biomedical models during the 1950`s mental health care has changed and evolved. The dependency on the sole use of medication was found to have left patients with residual symptoms and social disability, including difficulty with interpersonal skills and limitation with coping
Since the mental disorders that were discussed alter the individual’s cognitive process such as attention in similar ways, it is healthier to seek therapy that are concentrated in areas that would help improve the patient’s emotions, and better yet, to find a method that will lead to better control of the person’s feelings and sensations. It is also important for anyone dealing with a mental disorder, that the best therapy in the long run would be a therapy approach that centralizes in treating all aspects of the illness. For example, a person who is taking medication and at the same time is taking cognitive behavioral therapy, when dealing with
Preston, J., O'Neal, J. H., & Talaga, M. C. (2013). Handbook of clinical psychopharmacology for therapists (7th ed.). Oakland, CA: New
Adherence to pharmacological treatment is essential for the alleviation of psychotic symptoms in schizophrenia. To ensure mediational adherence, the social workers started inpatient therapeutic services with CBT counseling. The goal was to assist Peter with identifying and modifying cognitive and motivational barriers to adherence. In this case, insurance, cost, and access was a determining factor that hindered Peter’s adherence. The primary social work was able to utilize their roles as advocates to successful reenrolled Peter into his medical insurance plan. They were able to connect him to a payee and a case management agency. They ensured devilry of Peter’s medication by calling his local pharmacy and arranged Peter’s follow-up appointment
Pharmacological interventions is a must for patients experiencing schizophrenia, but non pharmacological interventions are always important as well. Non-pharmacological interventions range from coping skills all the way to therapy. Other mental disorders may not require as strenuous of interventions because the disease process is not as dangerous. For instance, for mood disorders, exercise and eating correctly are two very easy non pharmacological interventions a client can implement to better their disease process. With schizophrenia it is often harder because to clients have to gain insight, and understand why they must perform these non pharmacological
With a combination of antipsychotic medications, it is the most frequently implemented treatment offered to patients (Fenton, 2000). Individual psychotherapy confronts the human components of adaption and targets problems that follows such as: symptoms, relapse, denial, discouragement, treatment agreement, interpersonal relationships, and self-esteem. Since this approach’s attention is understanding the patient’s views, attitudes, ambitions, and experiences; clinicians will continue to implement this method (Fenton, 2000). Another approach for treatment of schizophrenia is family psychoeducation (FPE). This method has been established as one of the most effective psychosocial treatments developed. It integrates a patient’s family, caregivers, and friends into important and constant treatment and rehabilitation (McFarlane, 2016). In further detail, FPE consists of cognitive, behavioral, and helpful therapeutic features while utilizing a counseling structure. Overall, FPE has reduced the percentage of relapse for persons suffering from schizophrenia to 40% (McFarlane,
First, a group of researchers conducts a literature review and found that their data suggests that treatment by psychotropic medication possess a greater possibility of negative side effects than other treatment options (Shapiro et al., 2007). The same researchers state that the current literature weakly supports the idea that a combination of psychotropic medication and cognitive-behavioral therapy is superior to treatment by medication alone, but that more research in this area should be done (Shapiro et al., 2007). Comer argues that treatment by medication is the most effective when combined with some other treatment
Studies have been done on the cognitive behavior and medication. Some studies looked at the behavior with bipolar disorder and the medication that they take for the (Micheal Bauer, Tasha Glenn, Paul Grof, Natalie L Rasgon, Wendy Marsh, Kemal Sagduyu, Martin Alda, Ute Lewitzka, Rita Schmid, &Perter C Whybrow 2009). Some studies focus on depression treatment and the serotonin reuptake (Benedetto Vitello 2009), (Sonya S. Descheˆnes • Michel J. Dugas 2012) (Bjo¨ rn Paxling, Jonas Almlo¨ v1, Mats Dahlin, Per Carlbring, Elisabeth Breitholtz, Thomas Eriksson6 and Gerhard Andersson 2011), and (Alastair J. Flint 2005). Each study is focused on the behavior of patients with behavioral medicine. Studies also focus on the cognitive behavior. The purpose of this literature review is to show how research of behavioral medicines can affect the cognitive behavior of a person with treatment of medication. It also to show how different medication affect the treatment of patients in the clinical trials.
Although, it says promising results have been published, the treatment literature for bipolar disorder is said to be during infancy (Craighead & Miklowitz, 2000). Psychologists Perry, Tarrier, Morriss, McCarthy, and Limb found that when medicinal remedies were administered with an independently cognitive and behavioral rehabilitation at early recognition of prodromal symptoms, that these combined techniques were more effective in delaying relapses over an 18 month follow up than versus a medication only intervention (Perry, Tarrier, Morriss, McCarthy, and Limb, 1999). Exact figures also suggest that patients treated with a distinctive therapy, maintenance interpersonal, and medication is more likely to preserve a stable state rather than patients given an intensive clinical supervision intervention and medication (Frank, 1999). Hogarty, a psychologist, presented that a family psychoeducational treatment and pharmacotherapy had more permanent effects than individual social skills coaching and pharmacotherapy, but this was in terms of community survivorship in 1 and 2 year follow-ups of schizophrenic patients (Hogarty, 1991). Ultimately it resulted that inclusion of the family in the "outpatient management of schizophrenia has received strong support from the empirical literature, although questions remain about which forms of family treatment are most effective" (Goldstein & Miklowitz, 1995). Psychologists observed that
For treatment of psychosis, antipsychotic medication is offered in conjunction with psychological interventions, which entails family intervention with individual cognitive behavioral therapy. For a patient to have the most effective results in treatment it is advised that both interventions are done together, that is taking an oral antipsychotic medication and psychological interventions with therapy. The parents will more than likely be deciding on the antipsychotic medication offered by the mental health service specialist. The parents and patient should be aware of the benefits and side effects of the drug such as metabolic changes, extrapyramidal effects, cardiovascular, hormonal and other changes that may occur. Baseline overall health should be recorded prior and during oral anti-psychotic therapy. Therapy sessions are in place to further support the adolescent in treatment. Hospital care may be referred if a case becomes unavoidable.
Treatment of persons with mental illness involves a team approach in which the nurses plays a major role of monitoring and effectively implementing the established standards of practice in psychosocial and psychopharmaco therapies. Even though psychotropic medications has seen the major development in recent decades, they are not completely without side effects. This makes vigilant monitoring approach towards prevention and treatment of side effects along with adherence therapy, a challenge to mental health professionals.